Muzammil Mansuri
About Muzammil Mansuri
Muzammil Mansuri is a Senior Strategic Advisor and Venture Partner at F-Prime Capital, with extensive experience in executive roles at Sanofi, Gilead Sciences, and CGI Pharmaceuticals.
Muzammil Mansuri Venture Partner at F-Prime Capital
Muzammil Mansuri is currently a Venture Partner at F-Prime Capital. F-Prime Capital is a global venture capital firm that invests in healthcare and technology. In this role, Muzammil leverages his extensive experience in research and development, corporate strategy, and business development to support the firm's investment strategies. His role involves identifying promising ventures, guiding startup growth, and providing strategic insights to portfolio companies.
Muzammil Mansuri Former Executive Vice President at Sanofi
Muzammil Mansuri previously served as Executive Vice President, Strategy, Business Development, and Licensing at Sanofi. During his tenure at Sanofi, he was responsible for shaping the company's strategy, driving business development initiatives, and managing licensing activities. His work contributed to Sanofi's growth and expansion in the pharmaceutical industry. This role showcased his ability to lead high-level strategic operations within a major global pharmaceutical company.
Muzammil Mansuri Senior Vice President at Gilead Sciences
Before his tenure at Sanofi, Muzammil Mansuri held the position of Senior Vice President of Research & Development Strategy and Corporate Development at Gilead Sciences. In this capacity, he played a vital role in steering the company's R&D strategy and overseeing corporate development. This position allowed him to influence significant decisions related to Gilead's research, development, and strategic growth initiatives.
Muzammil Mansuri Chairman and CEO of CGI Pharmaceuticals
Muzammil Mansuri was the Chairman and CEO of CGI Pharmaceuticals, a biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics. Under his leadership, CGI Pharmaceuticals was acquired by Gilead Sciences in 2010. This acquisition was a key milestone in his career, highlighting his ability to lead and develop biotech companies to successful exits.
Muzammil Mansuri Education and Early Career
Muzammil Mansuri holds a PhD in Organic Chemistry and a BS in Chemistry from University College London. Following his academic training, he held post-doctoral research positions at the University of California, Los Angeles (UCLA) and Columbia University. He began his professional career as a bench medicinal chemist at Bristol-Myers, where he gained foundational experience in the pharmaceutical industry. His educational background and early career roles laid the groundwork for his extensive expertise in medicinal chemistry and drug development.